nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluoperazine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0545	0.1	CbGbCtD
Trifluoperazine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0512	0.094	CbGbCtD
Trifluoperazine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0512	0.094	CbGbCtD
Trifluoperazine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0463	0.085	CbGbCtD
Trifluoperazine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0448	0.0822	CbGbCtD
Trifluoperazine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0405	0.0743	CbGbCtD
Trifluoperazine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0388	0.0712	CbGbCtD
Trifluoperazine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0351	0.0644	CbGbCtD
Trifluoperazine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.035	0.0642	CbGbCtD
Trifluoperazine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.034	0.0623	CbGbCtD
Trifluoperazine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0307	0.0563	CbGbCtD
Trifluoperazine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0307	0.0563	CbGbCtD
Trifluoperazine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0294	0.054	CbGbCtD
Trifluoperazine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0228	0.0418	CbGbCtD
Trifluoperazine—S100A4—blood plasma—acquired immunodeficiency syndrome	0.00586	0.0415	CbGeAlD
Trifluoperazine—UGT1A4—blood plasma—acquired immunodeficiency syndrome	0.00514	0.0365	CbGeAlD
Trifluoperazine—CALM2—semen—acquired immunodeficiency syndrome	0.00463	0.0328	CbGeAlD
Trifluoperazine—CALM1—semen—acquired immunodeficiency syndrome	0.00461	0.0327	CbGeAlD
Trifluoperazine—S100A4—skin of body—acquired immunodeficiency syndrome	0.00282	0.02	CbGeAlD
Trifluoperazine—CALY—spinal cord—acquired immunodeficiency syndrome	0.0024	0.017	CbGeAlD
Trifluoperazine—EBPL—lung—acquired immunodeficiency syndrome	0.00238	0.0169	CbGeAlD
Trifluoperazine—S100A4—lymphoid tissue—acquired immunodeficiency syndrome	0.00228	0.0162	CbGeAlD
Trifluoperazine—S100A4—digestive system—acquired immunodeficiency syndrome	0.00225	0.016	CbGeAlD
Trifluoperazine—CALM2—nerve—acquired immunodeficiency syndrome	0.00223	0.0158	CbGeAlD
Trifluoperazine—CALM1—nerve—acquired immunodeficiency syndrome	0.00222	0.0157	CbGeAlD
Trifluoperazine—EBPL—nervous system—acquired immunodeficiency syndrome	0.00221	0.0156	CbGeAlD
Trifluoperazine—S100A4—blood—acquired immunodeficiency syndrome	0.00215	0.0152	CbGeAlD
Trifluoperazine—EBPL—central nervous system—acquired immunodeficiency syndrome	0.00212	0.0151	CbGeAlD
Trifluoperazine—S100A4—bone marrow—acquired immunodeficiency syndrome	0.00208	0.0147	CbGeAlD
Trifluoperazine—S100A4—spinal cord—acquired immunodeficiency syndrome	0.00207	0.0147	CbGeAlD
Trifluoperazine—DRD2—nerve—acquired immunodeficiency syndrome	0.00205	0.0145	CbGeAlD
Trifluoperazine—CALY—nervous system—acquired immunodeficiency syndrome	0.00202	0.0143	CbGeAlD
Trifluoperazine—S100A4—vagina—acquired immunodeficiency syndrome	0.00199	0.0141	CbGeAlD
Trifluoperazine—UGT1A4—digestive system—acquired immunodeficiency syndrome	0.00198	0.014	CbGeAlD
Trifluoperazine—CALY—central nervous system—acquired immunodeficiency syndrome	0.00194	0.0138	CbGeAlD
Trifluoperazine—CALM2—endothelium—acquired immunodeficiency syndrome	0.0019	0.0135	CbGeAlD
Trifluoperazine—CALM1—endothelium—acquired immunodeficiency syndrome	0.00189	0.0134	CbGeAlD
Trifluoperazine—UGT1A4—blood—acquired immunodeficiency syndrome	0.00188	0.0134	CbGeAlD
Trifluoperazine—S100A4—lung—acquired immunodeficiency syndrome	0.00188	0.0133	CbGeAlD
Trifluoperazine—TNNC1—blood—acquired immunodeficiency syndrome	0.00181	0.0128	CbGeAlD
Trifluoperazine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00172	0.0122	CbGeAlD
Trifluoperazine—EBPL—brain—acquired immunodeficiency syndrome	0.00169	0.012	CbGeAlD
Trifluoperazine—CALM2—blood plasma—acquired immunodeficiency syndrome	0.00169	0.012	CbGeAlD
Trifluoperazine—CALM1—blood plasma—acquired immunodeficiency syndrome	0.00168	0.0119	CbGeAlD
Trifluoperazine—EBPL—lymph node—acquired immunodeficiency syndrome	0.00163	0.0116	CbGeAlD
Trifluoperazine—TNNC1—lung—acquired immunodeficiency syndrome	0.00158	0.0112	CbGeAlD
Trifluoperazine—CALY—brain—acquired immunodeficiency syndrome	0.00154	0.0109	CbGeAlD
Trifluoperazine—CALY—lymph node—acquired immunodeficiency syndrome	0.00149	0.0106	CbGeAlD
Trifluoperazine—XDH—digestive system—acquired immunodeficiency syndrome	0.00144	0.0102	CbGeAlD
Trifluoperazine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00135	0.00959	CbGeAlD
Trifluoperazine—S100A4—brain—acquired immunodeficiency syndrome	0.00133	0.00944	CbGeAlD
Trifluoperazine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00131	0.00927	CbGeAlD
Trifluoperazine—S100A4—lymph node—acquired immunodeficiency syndrome	0.00129	0.00912	CbGeAlD
Trifluoperazine—XDH—vagina—acquired immunodeficiency syndrome	0.00127	0.00903	CbGeAlD
Trifluoperazine—CALM3—retina—acquired immunodeficiency syndrome	0.00118	0.00834	CbGeAlD
Trifluoperazine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00115	0.00816	CbGeAlD
Trifluoperazine—TNNC1—lymph node—acquired immunodeficiency syndrome	0.00108	0.00768	CbGeAlD
Trifluoperazine—HTR6—nervous system—acquired immunodeficiency syndrome	0.00105	0.00744	CbGeAlD
Trifluoperazine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00102	0.00725	CbGeAlD
Trifluoperazine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.00101	0.00716	CbGeAlD
Trifluoperazine—CALM2—retina—acquired immunodeficiency syndrome	0.000924	0.00655	CbGeAlD
Trifluoperazine—CALM1—retina—acquired immunodeficiency syndrome	0.000919	0.00652	CbGeAlD
Trifluoperazine—DRD2—retina—acquired immunodeficiency syndrome	0.000849	0.00602	CbGeAlD
Trifluoperazine—CALM2—skin of body—acquired immunodeficiency syndrome	0.000811	0.00575	CbGeAlD
Trifluoperazine—CALM1—skin of body—acquired immunodeficiency syndrome	0.000807	0.00572	CbGeAlD
Trifluoperazine—HTR6—brain—acquired immunodeficiency syndrome	0.000802	0.00569	CbGeAlD
Trifluoperazine—CALM3—blood—acquired immunodeficiency syndrome	0.000787	0.00558	CbGeAlD
Trifluoperazine—CALM3—bone marrow—acquired immunodeficiency syndrome	0.000761	0.0054	CbGeAlD
Trifluoperazine—CALM3—spinal cord—acquired immunodeficiency syndrome	0.000758	0.00537	CbGeAlD
Trifluoperazine—CALM3—vagina—acquired immunodeficiency syndrome	0.000729	0.00517	CbGeAlD
Trifluoperazine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00072	0.0051	CbGeAlD
Trifluoperazine—SIGMAR1—blood—acquired immunodeficiency syndrome	0.000703	0.00499	CbGeAlD
Trifluoperazine—CALM3—lung—acquired immunodeficiency syndrome	0.00069	0.00489	CbGeAlD
Trifluoperazine—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.00068	0.00482	CbGeAlD
Trifluoperazine—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.000678	0.0048	CbGeAlD
Trifluoperazine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00067	0.00475	CbGeAlD
Trifluoperazine—CALM2—lymphoid tissue—acquired immunodeficiency syndrome	0.000657	0.00465	CbGeAlD
Trifluoperazine—CALM1—lymphoid tissue—acquired immunodeficiency syndrome	0.000654	0.00463	CbGeAlD
Trifluoperazine—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.000652	0.00462	CbGeAlD
Trifluoperazine—CALM2—digestive system—acquired immunodeficiency syndrome	0.000649	0.0046	CbGeAlD
Trifluoperazine—CALM1—digestive system—acquired immunodeficiency syndrome	0.000646	0.00458	CbGeAlD
Trifluoperazine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000629	0.00446	CbGeAlD
Trifluoperazine—CALM2—blood—acquired immunodeficiency syndrome	0.000618	0.00438	CbGeAlD
Trifluoperazine—SIGMAR1—lung—acquired immunodeficiency syndrome	0.000616	0.00437	CbGeAlD
Trifluoperazine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000616	0.00437	CbGeAlD
Trifluoperazine—CALM1—blood—acquired immunodeficiency syndrome	0.000615	0.00436	CbGeAlD
Trifluoperazine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000606	0.0043	CbGeAlD
Trifluoperazine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000606	0.00429	CbGeAlD
Trifluoperazine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000606	0.00429	CbGeAlD
Trifluoperazine—CALM2—bone marrow—acquired immunodeficiency syndrome	0.000598	0.00424	CbGeAlD
Trifluoperazine—CALM2—spinal cord—acquired immunodeficiency syndrome	0.000595	0.00422	CbGeAlD
Trifluoperazine—CALM1—bone marrow—acquired immunodeficiency syndrome	0.000595	0.00422	CbGeAlD
Trifluoperazine—CALM1—spinal cord—acquired immunodeficiency syndrome	0.000593	0.0042	CbGeAlD
Trifluoperazine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000584	0.00414	CbGeAlD
Trifluoperazine—ADRA1A—blood—acquired immunodeficiency syndrome	0.00058	0.00411	CbGeAlD
Trifluoperazine—CALM2—vagina—acquired immunodeficiency syndrome	0.000573	0.00406	CbGeAlD
Trifluoperazine—CALM1—vagina—acquired immunodeficiency syndrome	0.00057	0.00404	CbGeAlD
Trifluoperazine—HTR2A—retina—acquired immunodeficiency syndrome	0.00056	0.00397	CbGeAlD
Trifluoperazine—CALM2—lung—acquired immunodeficiency syndrome	0.000542	0.00384	CbGeAlD
Trifluoperazine—CALM1—lung—acquired immunodeficiency syndrome	0.000539	0.00382	CbGeAlD
Trifluoperazine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.00051	0.00362	CbGeAlD
Trifluoperazine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000503	0.00357	CbGeAlD
Trifluoperazine—CALM2—nervous system—acquired immunodeficiency syndrome	0.000502	0.00356	CbGeAlD
Trifluoperazine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000501	0.00202	CcSEcCtD
Trifluoperazine—CALM1—nervous system—acquired immunodeficiency syndrome	0.000499	0.00354	CbGeAlD
Trifluoperazine—DRD2—lung—acquired immunodeficiency syndrome	0.000498	0.00353	CbGeAlD
Trifluoperazine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000496	0.002	CcSEcCtD
Trifluoperazine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000495	0.00199	CcSEcCtD
Trifluoperazine—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.000495	0.00199	CcSEcCtD
Trifluoperazine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000494	0.00199	CcSEcCtD
Trifluoperazine—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.000494	0.00199	CcSEcCtD
Trifluoperazine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000493	0.00199	CcSEcCtD
Trifluoperazine—Angioedema—Indinavir—acquired immunodeficiency syndrome	0.000492	0.00198	CcSEcCtD
Trifluoperazine—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.000492	0.00198	CcSEcCtD
Trifluoperazine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000491	0.00348	CbGeAlD
Trifluoperazine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.00049	0.00197	CcSEcCtD
Trifluoperazine—CALM3—brain—acquired immunodeficiency syndrome	0.000488	0.00346	CbGeAlD
Trifluoperazine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.000487	0.00196	CcSEcCtD
Trifluoperazine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000487	0.00196	CcSEcCtD
Trifluoperazine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000486	0.00196	CcSEcCtD
Trifluoperazine—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000486	0.00196	CcSEcCtD
Trifluoperazine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000485	0.00195	CcSEcCtD
Trifluoperazine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.000485	0.00195	CcSEcCtD
Trifluoperazine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000484	0.00195	CcSEcCtD
Trifluoperazine—CALM2—central nervous system—acquired immunodeficiency syndrome	0.000483	0.00342	CbGeAlD
Trifluoperazine—CHRM2—brain—acquired immunodeficiency syndrome	0.000481	0.00341	CbGeAlD
Trifluoperazine—CALM1—central nervous system—acquired immunodeficiency syndrome	0.000481	0.00341	CbGeAlD
Trifluoperazine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00048	0.00193	CcSEcCtD
Trifluoperazine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000479	0.0034	CbGeAlD
Trifluoperazine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000478	0.00192	CcSEcCtD
Trifluoperazine—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000477	0.00192	CcSEcCtD
Trifluoperazine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000475	0.00191	CcSEcCtD
Trifluoperazine—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.000473	0.00191	CcSEcCtD
Trifluoperazine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000473	0.00191	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.000473	0.0019	CcSEcCtD
Trifluoperazine—CALM3—lymph node—acquired immunodeficiency syndrome	0.000472	0.00334	CbGeAlD
Trifluoperazine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000471	0.00334	CbGeAlD
Trifluoperazine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.00047	0.00334	CbGeAlD
Trifluoperazine—Cough—Indinavir—acquired immunodeficiency syndrome	0.00047	0.00189	CcSEcCtD
Trifluoperazine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000469	0.00189	CcSEcCtD
Trifluoperazine—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000468	0.00189	CcSEcCtD
Trifluoperazine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000468	0.00188	CcSEcCtD
Trifluoperazine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000466	0.00188	CcSEcCtD
Trifluoperazine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000465	0.00187	CcSEcCtD
Trifluoperazine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000465	0.00187	CcSEcCtD
Trifluoperazine—HTR2C—brain—acquired immunodeficiency syndrome	0.000463	0.00329	CbGeAlD
Trifluoperazine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000462	0.00186	CcSEcCtD
Trifluoperazine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000462	0.00186	CcSEcCtD
Trifluoperazine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000461	0.00327	CbGeAlD
Trifluoperazine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000459	0.00185	CcSEcCtD
Trifluoperazine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000459	0.00185	CcSEcCtD
Trifluoperazine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000456	0.00184	CcSEcCtD
Trifluoperazine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000453	0.00321	CbGeAlD
Trifluoperazine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000451	0.00182	CcSEcCtD
Trifluoperazine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00045	0.00181	CcSEcCtD
Trifluoperazine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000449	0.00181	CcSEcCtD
Trifluoperazine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000448	0.0018	CcSEcCtD
Trifluoperazine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000448	0.0018	CcSEcCtD
Trifluoperazine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000446	0.00179	CcSEcCtD
Trifluoperazine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000445	0.00179	CcSEcCtD
Trifluoperazine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000444	0.00179	CcSEcCtD
Trifluoperazine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000444	0.00315	CbGeAlD
Trifluoperazine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000443	0.00179	CcSEcCtD
Trifluoperazine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000441	0.00178	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00044	0.00177	CcSEcCtD
Trifluoperazine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000438	0.00176	CcSEcCtD
Trifluoperazine—SIGMAR1—brain—acquired immunodeficiency syndrome	0.000436	0.00309	CbGeAlD
Trifluoperazine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000436	0.00176	CcSEcCtD
Trifluoperazine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.000434	0.00175	CcSEcCtD
Trifluoperazine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000434	0.00175	CcSEcCtD
Trifluoperazine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000434	0.00175	CcSEcCtD
Trifluoperazine—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000433	0.00174	CcSEcCtD
Trifluoperazine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000433	0.00174	CcSEcCtD
Trifluoperazine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000432	0.00174	CcSEcCtD
Trifluoperazine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000432	0.00174	CcSEcCtD
Trifluoperazine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000431	0.00173	CcSEcCtD
Trifluoperazine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00043	0.00173	CcSEcCtD
Trifluoperazine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000428	0.00172	CcSEcCtD
Trifluoperazine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000427	0.00172	CcSEcCtD
Trifluoperazine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000426	0.00172	CcSEcCtD
Trifluoperazine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00171	CcSEcCtD
Trifluoperazine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000425	0.00171	CcSEcCtD
Trifluoperazine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000424	0.00171	CcSEcCtD
Trifluoperazine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000424	0.00171	CcSEcCtD
Trifluoperazine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000422	0.0017	CcSEcCtD
Trifluoperazine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000422	0.0017	CcSEcCtD
Trifluoperazine—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.000422	0.00299	CbGeAlD
Trifluoperazine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00042	0.00169	CcSEcCtD
Trifluoperazine—CYP1A2—lung—acquired immunodeficiency syndrome	0.00042	0.00298	CbGeAlD
Trifluoperazine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000419	0.00169	CcSEcCtD
Trifluoperazine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.00168	CcSEcCtD
Trifluoperazine—HRH1—vagina—acquired immunodeficiency syndrome	0.000416	0.00295	CbGeAlD
Trifluoperazine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000415	0.00167	CcSEcCtD
Trifluoperazine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000414	0.00167	CcSEcCtD
Trifluoperazine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.000414	0.00167	CcSEcCtD
Trifluoperazine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000411	0.00166	CcSEcCtD
Trifluoperazine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000408	0.00164	CcSEcCtD
Trifluoperazine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000408	0.00164	CcSEcCtD
Trifluoperazine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000406	0.00164	CcSEcCtD
Trifluoperazine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000406	0.00163	CcSEcCtD
Trifluoperazine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000404	0.00163	CcSEcCtD
Trifluoperazine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000404	0.00163	CcSEcCtD
Trifluoperazine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000404	0.00163	CcSEcCtD
Trifluoperazine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000403	0.00162	CcSEcCtD
Trifluoperazine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000402	0.00162	CcSEcCtD
Trifluoperazine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000402	0.00162	CcSEcCtD
Trifluoperazine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000401	0.00161	CcSEcCtD
Trifluoperazine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000399	0.00161	CcSEcCtD
Trifluoperazine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000399	0.00161	CcSEcCtD
Trifluoperazine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000398	0.0016	CcSEcCtD
Trifluoperazine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000398	0.0016	CcSEcCtD
Trifluoperazine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000396	0.0016	CcSEcCtD
Trifluoperazine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000395	0.00159	CcSEcCtD
Trifluoperazine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000395	0.00159	CcSEcCtD
Trifluoperazine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000395	0.00159	CcSEcCtD
Trifluoperazine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000393	0.00279	CbGeAlD
Trifluoperazine—HRH1—lung—acquired immunodeficiency syndrome	0.000393	0.00279	CbGeAlD
Trifluoperazine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.00158	CcSEcCtD
Trifluoperazine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000393	0.00158	CcSEcCtD
Trifluoperazine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000392	0.00158	CcSEcCtD
Trifluoperazine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000392	0.00158	CcSEcCtD
Trifluoperazine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000391	0.00157	CcSEcCtD
Trifluoperazine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00039	0.00157	CcSEcCtD
Trifluoperazine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00039	0.00157	CcSEcCtD
Trifluoperazine—HTR1A—brain—acquired immunodeficiency syndrome	0.00039	0.00277	CbGeAlD
Trifluoperazine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000388	0.00156	CcSEcCtD
Trifluoperazine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000388	0.00156	CcSEcCtD
Trifluoperazine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000386	0.00156	CcSEcCtD
Trifluoperazine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000386	0.00156	CcSEcCtD
Trifluoperazine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000385	0.00155	CcSEcCtD
Trifluoperazine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000385	0.00155	CcSEcCtD
Trifluoperazine—CALM2—brain—acquired immunodeficiency syndrome	0.000383	0.00272	CbGeAlD
Trifluoperazine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000382	0.00154	CcSEcCtD
Trifluoperazine—CALM1—brain—acquired immunodeficiency syndrome	0.000382	0.00271	CbGeAlD
Trifluoperazine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000379	0.00153	CcSEcCtD
Trifluoperazine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000379	0.00153	CcSEcCtD
Trifluoperazine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000379	0.00153	CcSEcCtD
Trifluoperazine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00152	CcSEcCtD
Trifluoperazine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000378	0.00152	CcSEcCtD
Trifluoperazine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000376	0.00151	CcSEcCtD
Trifluoperazine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000376	0.00151	CcSEcCtD
Trifluoperazine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000376	0.00151	CcSEcCtD
Trifluoperazine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000376	0.00151	CcSEcCtD
Trifluoperazine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000375	0.00151	CcSEcCtD
Trifluoperazine—HTR2A—blood—acquired immunodeficiency syndrome	0.000375	0.00266	CbGeAlD
Trifluoperazine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000374	0.00151	CcSEcCtD
Trifluoperazine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000372	0.0015	CcSEcCtD
Trifluoperazine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000372	0.0015	CcSEcCtD
Trifluoperazine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000371	0.00149	CcSEcCtD
Trifluoperazine—CALM2—lymph node—acquired immunodeficiency syndrome	0.00037	0.00263	CbGeAlD
Trifluoperazine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00037	0.00149	CcSEcCtD
Trifluoperazine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000369	0.00149	CcSEcCtD
Trifluoperazine—CALM1—lymph node—acquired immunodeficiency syndrome	0.000369	0.00261	CbGeAlD
Trifluoperazine—ABCB1—retina—acquired immunodeficiency syndrome	0.000367	0.0026	CbGeAlD
Trifluoperazine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000364	0.00258	CbGeAlD
Trifluoperazine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000361	0.00146	CcSEcCtD
Trifluoperazine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000361	0.00145	CcSEcCtD
Trifluoperazine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00145	CcSEcCtD
Trifluoperazine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000361	0.00256	CbGeAlD
Trifluoperazine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000361	0.00145	CcSEcCtD
Trifluoperazine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00036	0.00145	CcSEcCtD
Trifluoperazine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00036	0.00145	CcSEcCtD
Trifluoperazine—ADRA1A—brain—acquired immunodeficiency syndrome	0.00036	0.00255	CbGeAlD
Trifluoperazine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000358	0.00144	CcSEcCtD
Trifluoperazine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000358	0.00144	CcSEcCtD
Trifluoperazine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000357	0.00144	CcSEcCtD
Trifluoperazine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00143	CcSEcCtD
Trifluoperazine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000355	0.00143	CcSEcCtD
Trifluoperazine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000355	0.00143	CcSEcCtD
Trifluoperazine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000355	0.00143	CcSEcCtD
Trifluoperazine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000354	0.00143	CcSEcCtD
Trifluoperazine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000354	0.00142	CcSEcCtD
Trifluoperazine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000353	0.00142	CcSEcCtD
Trifluoperazine—DRD2—brain—acquired immunodeficiency syndrome	0.000352	0.0025	CbGeAlD
Trifluoperazine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000351	0.00249	CbGeAlD
Trifluoperazine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000351	0.00141	CcSEcCtD
Trifluoperazine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000349	0.00141	CcSEcCtD
Trifluoperazine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000348	0.0014	CcSEcCtD
Trifluoperazine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000347	0.00246	CbGeAlD
Trifluoperazine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000346	0.00139	CcSEcCtD
Trifluoperazine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000344	0.00139	CcSEcCtD
Trifluoperazine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000344	0.00139	CcSEcCtD
Trifluoperazine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000344	0.00138	CcSEcCtD
Trifluoperazine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000344	0.00138	CcSEcCtD
Trifluoperazine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000344	0.00138	CcSEcCtD
Trifluoperazine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000343	0.00138	CcSEcCtD
Trifluoperazine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000343	0.00138	CcSEcCtD
Trifluoperazine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000343	0.00138	CcSEcCtD
Trifluoperazine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000342	0.00138	CcSEcCtD
Trifluoperazine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000341	0.00137	CcSEcCtD
Trifluoperazine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00137	CcSEcCtD
Trifluoperazine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000339	0.00137	CcSEcCtD
Trifluoperazine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000338	0.00136	CcSEcCtD
Trifluoperazine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000338	0.00136	CcSEcCtD
Trifluoperazine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.00136	CcSEcCtD
Trifluoperazine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.00136	CcSEcCtD
Trifluoperazine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000336	0.00135	CcSEcCtD
Trifluoperazine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000335	0.00135	CcSEcCtD
Trifluoperazine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000335	0.00135	CcSEcCtD
Trifluoperazine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000333	0.00134	CcSEcCtD
Trifluoperazine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000331	0.00133	CcSEcCtD
Trifluoperazine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00033	0.00133	CcSEcCtD
Trifluoperazine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000329	0.00132	CcSEcCtD
Trifluoperazine—HTR2A—lung—acquired immunodeficiency syndrome	0.000328	0.00233	CbGeAlD
Trifluoperazine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000328	0.00132	CcSEcCtD
Trifluoperazine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000328	0.00132	CcSEcCtD
Trifluoperazine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00132	CcSEcCtD
Trifluoperazine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000324	0.00131	CcSEcCtD
Trifluoperazine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000324	0.00131	CcSEcCtD
Trifluoperazine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000323	0.0013	CcSEcCtD
Trifluoperazine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000322	0.0013	CcSEcCtD
Trifluoperazine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00032	0.00129	CcSEcCtD
Trifluoperazine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.00129	CcSEcCtD
Trifluoperazine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000318	0.00128	CcSEcCtD
Trifluoperazine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000317	0.00128	CcSEcCtD
Trifluoperazine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.00127	CcSEcCtD
Trifluoperazine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000316	0.00127	CcSEcCtD
Trifluoperazine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000316	0.00127	CcSEcCtD
Trifluoperazine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000315	0.00127	CcSEcCtD
Trifluoperazine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000315	0.00127	CcSEcCtD
Trifluoperazine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.00127	CcSEcCtD
Trifluoperazine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000314	0.00127	CcSEcCtD
Trifluoperazine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000313	0.00126	CcSEcCtD
Trifluoperazine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000311	0.00125	CcSEcCtD
Trifluoperazine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.00124	CcSEcCtD
Trifluoperazine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.00123	CcSEcCtD
Trifluoperazine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.00123	CcSEcCtD
Trifluoperazine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000305	0.00123	CcSEcCtD
Trifluoperazine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000304	0.00216	CbGeAlD
Trifluoperazine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.00122	CcSEcCtD
Trifluoperazine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000301	0.00121	CcSEcCtD
Trifluoperazine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.0003	0.00121	CcSEcCtD
Trifluoperazine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.0012	CcSEcCtD
Trifluoperazine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000298	0.0012	CcSEcCtD
Trifluoperazine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.0012	CcSEcCtD
Trifluoperazine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00119	CcSEcCtD
Trifluoperazine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000294	0.00118	CcSEcCtD
Trifluoperazine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.00118	CcSEcCtD
Trifluoperazine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000293	0.00118	CcSEcCtD
Trifluoperazine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000293	0.00208	CbGeAlD
Trifluoperazine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.00118	CcSEcCtD
Trifluoperazine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000291	0.00117	CcSEcCtD
Trifluoperazine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000291	0.00117	CcSEcCtD
Trifluoperazine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000291	0.00117	CcSEcCtD
Trifluoperazine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00116	CcSEcCtD
Trifluoperazine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000285	0.00115	CcSEcCtD
Trifluoperazine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000281	0.00113	CcSEcCtD
Trifluoperazine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.00113	CcSEcCtD
Trifluoperazine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000281	0.00113	CcSEcCtD
Trifluoperazine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00028	0.00113	CcSEcCtD
Trifluoperazine—HRH1—brain—acquired immunodeficiency syndrome	0.000278	0.00197	CbGeAlD
Trifluoperazine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00112	CcSEcCtD
Trifluoperazine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00112	CcSEcCtD
Trifluoperazine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000276	0.00111	CcSEcCtD
Trifluoperazine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.00111	CcSEcCtD
Trifluoperazine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00109	CcSEcCtD
Trifluoperazine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000269	0.00191	CbGeAlD
Trifluoperazine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.00108	CcSEcCtD
Trifluoperazine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000267	0.00107	CcSEcCtD
Trifluoperazine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.00106	CcSEcCtD
Trifluoperazine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00106	CcSEcCtD
Trifluoperazine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00106	CcSEcCtD
Trifluoperazine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Trifluoperazine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000261	0.00105	CcSEcCtD
Trifluoperazine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000261	0.00185	CbGeAlD
Trifluoperazine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.00105	CcSEcCtD
Trifluoperazine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00105	CcSEcCtD
Trifluoperazine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00105	CcSEcCtD
Trifluoperazine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000258	0.00183	CbGeAlD
Trifluoperazine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00102	CcSEcCtD
Trifluoperazine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000251	0.00101	CcSEcCtD
Trifluoperazine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.00101	CcSEcCtD
Trifluoperazine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.00101	CcSEcCtD
Trifluoperazine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.001	CcSEcCtD
Trifluoperazine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.001	CcSEcCtD
Trifluoperazine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000247	0.000994	CcSEcCtD
Trifluoperazine—ABCB1—blood—acquired immunodeficiency syndrome	0.000246	0.00174	CbGeAlD
Trifluoperazine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.000979	CcSEcCtD
Trifluoperazine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000976	CcSEcCtD
Trifluoperazine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000962	CcSEcCtD
Trifluoperazine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000238	0.00168	CbGeAlD
Trifluoperazine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000237	0.00168	CbGeAlD
Trifluoperazine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.000951	CcSEcCtD
Trifluoperazine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.000943	CcSEcCtD
Trifluoperazine—HTR2A—brain—acquired immunodeficiency syndrome	0.000232	0.00165	CbGeAlD
Trifluoperazine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000934	CcSEcCtD
Trifluoperazine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000232	0.000933	CcSEcCtD
Trifluoperazine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000928	CcSEcCtD
Trifluoperazine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000228	0.00161	CbGeAlD
Trifluoperazine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.000899	CcSEcCtD
Trifluoperazine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000899	CcSEcCtD
Trifluoperazine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.000898	CcSEcCtD
Trifluoperazine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000893	CcSEcCtD
Trifluoperazine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.00088	CcSEcCtD
Trifluoperazine—ABCB1—lung—acquired immunodeficiency syndrome	0.000215	0.00153	CbGeAlD
Trifluoperazine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000857	CcSEcCtD
Trifluoperazine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000213	0.000857	CcSEcCtD
Trifluoperazine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000852	CcSEcCtD
Trifluoperazine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000847	CcSEcCtD
Trifluoperazine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.000808	CcSEcCtD
Trifluoperazine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000199	0.00141	CbGeAlD
Trifluoperazine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000192	0.00136	CbGeAlD
Trifluoperazine—ABCB1—brain—acquired immunodeficiency syndrome	0.000152	0.00108	CbGeAlD
Trifluoperazine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000147	0.00104	CbGeAlD
Trifluoperazine—Acepromazine—ALB—acquired immunodeficiency syndrome	0.000135	0.193	CrCbGaD
Trifluoperazine—Thioproperazine—ALB—acquired immunodeficiency syndrome	0.000132	0.189	CrCbGaD
Trifluoperazine—Pipotiazine—ALB—acquired immunodeficiency syndrome	0.00013	0.186	CrCbGaD
Trifluoperazine—Thiothixene—ALB—acquired immunodeficiency syndrome	0.00013	0.186	CrCbGaD
Trifluoperazine—Clomipramine—ALB—acquired immunodeficiency syndrome	0.000103	0.147	CrCbGaD
Trifluoperazine—Chlorpromazine—ALB—acquired immunodeficiency syndrome	7.03e-05	0.101	CrCbGaD
Trifluoperazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.69e-05	0.000416	CbGpPWpGaD
Trifluoperazine—CALM2—DAP12 signaling—IL6—acquired immunodeficiency syndrome	2.69e-05	0.000415	CbGpPWpGaD
Trifluoperazine—CALM1—DAP12 signaling—IL6—acquired immunodeficiency syndrome	2.69e-05	0.000415	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.68e-05	0.000414	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.66e-05	0.000411	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.64e-05	0.000409	CbGpPWpGaD
Trifluoperazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.64e-05	0.000408	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CCR2—acquired immunodeficiency syndrome	2.61e-05	0.000404	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CCR2—acquired immunodeficiency syndrome	2.61e-05	0.000404	CbGpPWpGaD
Trifluoperazine—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.61e-05	0.000404	CbGpPWpGaD
Trifluoperazine—CALM3—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.61e-05	0.000404	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.61e-05	0.000404	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.59e-05	0.0004	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.59e-05	0.0004	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.57e-05	0.000397	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.57e-05	0.000397	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.56e-05	0.000395	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.55e-05	0.000394	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.55e-05	0.000394	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.54e-05	0.000393	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.53e-05	0.000391	CbGpPWpGaD
Trifluoperazine—CALM2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.53e-05	0.000391	CbGpPWpGaD
Trifluoperazine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.53e-05	0.000391	CbGpPWpGaD
Trifluoperazine—CALM1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.53e-05	0.000391	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.53e-05	0.000391	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.53e-05	0.000391	CbGpPWpGaD
Trifluoperazine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.53e-05	0.000391	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.52e-05	0.00039	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.51e-05	0.000388	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.51e-05	0.000387	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.51e-05	0.000387	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.5e-05	0.000387	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.5e-05	0.000387	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.5e-05	0.000386	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.48e-05	0.000384	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.48e-05	0.000384	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.48e-05	0.000384	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.48e-05	0.000383	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.47e-05	0.000382	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.47e-05	0.000382	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.46e-05	0.000381	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.46e-05	0.00038	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.44e-05	0.000377	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IFNA1—acquired immunodeficiency syndrome	2.43e-05	0.000376	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.42e-05	0.000375	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—ALB—acquired immunodeficiency syndrome	2.37e-05	0.000366	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.37e-05	0.000366	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD79A—acquired immunodeficiency syndrome	2.36e-05	0.000365	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.35e-05	0.000364	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IFNA1—acquired immunodeficiency syndrome	2.35e-05	0.000364	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IFNA1—acquired immunodeficiency syndrome	2.35e-05	0.000364	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CXCR4—acquired immunodeficiency syndrome	2.35e-05	0.000363	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.33e-05	0.000361	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.33e-05	0.00036	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.32e-05	0.000359	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.32e-05	0.000359	CbGpPWpGaD
Trifluoperazine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.31e-05	0.000358	CbGpPWpGaD
Trifluoperazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.31e-05	0.000357	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.3e-05	0.000355	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.29e-05	0.000354	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.29e-05	0.000354	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.29e-05	0.000354	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—ALB—acquired immunodeficiency syndrome	2.29e-05	0.000354	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—ALB—acquired immunodeficiency syndrome	2.29e-05	0.000354	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.28e-05	0.000353	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD79A—acquired immunodeficiency syndrome	2.28e-05	0.000353	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD79A—acquired immunodeficiency syndrome	2.28e-05	0.000353	CbGpPWpGaD
Trifluoperazine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.28e-05	0.000353	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.28e-05	0.000352	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.28e-05	0.000352	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.28e-05	0.000352	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CXCR4—acquired immunodeficiency syndrome	2.27e-05	0.000351	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CXCR4—acquired immunodeficiency syndrome	2.27e-05	0.000351	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.25e-05	0.000349	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.25e-05	0.000348	CbGpPWpGaD
Trifluoperazine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.24e-05	0.000346	CbGpPWpGaD
Trifluoperazine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.24e-05	0.000346	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.14e-05	0.000331	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.12e-05	0.000328	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.12e-05	0.000327	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.1e-05	0.000325	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.1e-05	0.000325	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.08e-05	0.000322	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.07e-05	0.000321	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.07e-05	0.00032	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.06e-05	0.000319	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.05e-05	0.000316	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.05e-05	0.000316	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.02e-05	0.000312	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.02e-05	0.000312	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.01e-05	0.000311	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.01e-05	0.000311	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.98e-05	0.000306	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.98e-05	0.000306	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.97e-05	0.000305	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.97e-05	0.000305	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.94e-05	0.0003	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.94e-05	0.0003	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.94e-05	0.0003	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.94e-05	0.0003	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.93e-05	0.000299	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD40LG—acquired immunodeficiency syndrome	1.93e-05	0.000298	CbGpPWpGaD
Trifluoperazine—CALM3—Hemostasis—IL2—acquired immunodeficiency syndrome	1.92e-05	0.000297	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.91e-05	0.000295	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD8A—acquired immunodeficiency syndrome	1.9e-05	0.000294	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CSF2—acquired immunodeficiency syndrome	1.9e-05	0.000294	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.88e-05	0.00029	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.87e-05	0.000289	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.87e-05	0.000289	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD40LG—acquired immunodeficiency syndrome	1.86e-05	0.000288	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD40LG—acquired immunodeficiency syndrome	1.86e-05	0.000288	CbGpPWpGaD
Trifluoperazine—CALM1—Hemostasis—IL2—acquired immunodeficiency syndrome	1.86e-05	0.000287	CbGpPWpGaD
Trifluoperazine—CALM2—Hemostasis—IL2—acquired immunodeficiency syndrome	1.86e-05	0.000287	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.84e-05	0.000285	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.84e-05	0.000285	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD8A—acquired immunodeficiency syndrome	1.84e-05	0.000285	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD8A—acquired immunodeficiency syndrome	1.84e-05	0.000285	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CSF2—acquired immunodeficiency syndrome	1.84e-05	0.000285	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CSF2—acquired immunodeficiency syndrome	1.84e-05	0.000285	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—HLA-B—acquired immunodeficiency syndrome	1.83e-05	0.000283	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.82e-05	0.000281	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—CD4—acquired immunodeficiency syndrome	1.82e-05	0.000281	CbGpPWpGaD
Trifluoperazine—CALM3—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.8e-05	0.000279	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.78e-05	0.000275	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—HLA-B—acquired immunodeficiency syndrome	1.77e-05	0.000274	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—HLA-B—acquired immunodeficiency syndrome	1.77e-05	0.000274	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.75e-05	0.00027	CbGpPWpGaD
Trifluoperazine—CALM1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.74e-05	0.00027	CbGpPWpGaD
Trifluoperazine—CALM2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.74e-05	0.00027	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.74e-05	0.000269	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.73e-05	0.000268	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.72e-05	0.000266	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.72e-05	0.000266	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.72e-05	0.000265	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.71e-05	0.000264	CbGpPWpGaD
Trifluoperazine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.69e-05	0.000261	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.69e-05	0.000261	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.69e-05	0.000261	CbGpPWpGaD
Trifluoperazine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.68e-05	0.00026	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.64e-05	0.000254	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.64e-05	0.000254	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CCR5—acquired immunodeficiency syndrome	1.61e-05	0.000249	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.59e-05	0.000246	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.59e-05	0.000246	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.59e-05	0.000246	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.59e-05	0.000246	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.57e-05	0.000243	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.000241	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.00024	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.00024	CbGpPWpGaD
Trifluoperazine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.55e-05	0.00024	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.54e-05	0.000237	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.53e-05	0.000237	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.53e-05	0.000236	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.51e-05	0.000233	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.51e-05	0.000233	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.5e-05	0.000232	CbGpPWpGaD
Trifluoperazine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.48e-05	0.00023	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000229	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000229	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.48e-05	0.000229	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.47e-05	0.000228	CbGpPWpGaD
Trifluoperazine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000226	CbGpPWpGaD
Trifluoperazine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000225	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.46e-05	0.000225	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.45e-05	0.000224	CbGpPWpGaD
Trifluoperazine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000222	CbGpPWpGaD
Trifluoperazine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000221	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.38e-05	0.000213	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.00021	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000209	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000208	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000206	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.33e-05	0.000205	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000205	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000205	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000202	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.3e-05	0.000201	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.3e-05	0.000201	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.25e-05	0.000193	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.23e-05	0.00019	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000189	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.22e-05	0.000189	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.000187	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.000187	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.19e-05	0.000184	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.19e-05	0.000184	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IFNG—acquired immunodeficiency syndrome	1.13e-05	0.000175	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.13e-05	0.000174	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.1e-05	0.00017	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IFNG—acquired immunodeficiency syndrome	1.1e-05	0.000169	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IFNG—acquired immunodeficiency syndrome	1.1e-05	0.000169	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—CD4—acquired immunodeficiency syndrome	1.09e-05	0.000169	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.000168	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.000168	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000165	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—CD4—acquired immunodeficiency syndrome	1.06e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—CD4—acquired immunodeficiency syndrome	1.06e-05	0.000164	CbGpPWpGaD
Trifluoperazine—CALM3—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.02e-05	0.000157	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—CD4—acquired immunodeficiency syndrome	1.01e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000156	CbGpPWpGaD
Trifluoperazine—CALM2—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.82e-06	0.000152	CbGpPWpGaD
Trifluoperazine—CALM1—Innate Immune System—IL6—acquired immunodeficiency syndrome	9.82e-06	0.000152	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—CD4—acquired immunodeficiency syndrome	9.77e-06	0.000151	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—CD4—acquired immunodeficiency syndrome	9.77e-06	0.000151	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL2—acquired immunodeficiency syndrome	9.73e-06	0.00015	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL2—acquired immunodeficiency syndrome	9.73e-06	0.00015	CbGpPWpGaD
Trifluoperazine—CALM3—Metabolism—ALB—acquired immunodeficiency syndrome	9.59e-06	0.000148	CbGpPWpGaD
Trifluoperazine—CALM1—Metabolism—ALB—acquired immunodeficiency syndrome	9.28e-06	0.000143	CbGpPWpGaD
Trifluoperazine—CALM2—Metabolism—ALB—acquired immunodeficiency syndrome	9.28e-06	0.000143	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.07e-06	0.00014	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.02e-06	0.00014	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.02e-06	0.00014	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.98e-06	0.000139	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.96e-06	0.000123	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.92e-06	0.000123	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.84e-06	0.000121	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.82e-06	0.000121	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.8e-06	0.000121	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.78e-06	0.00012	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.69e-06	0.000119	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.67e-06	0.000119	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.66e-06	0.000118	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.63e-06	0.000118	CbGpPWpGaD
Trifluoperazine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	7.27e-06	0.000112	CbGpPWpGaD
Trifluoperazine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.2e-06	0.000111	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.5e-06	0.000101	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.47e-06	0.0001	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.29e-06	9.73e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.29e-06	9.73e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.26e-06	9.68e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.26e-06	9.68e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Immune System—IL6—acquired immunodeficiency syndrome	5.91e-06	9.14e-05	CbGpPWpGaD
Trifluoperazine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.8e-06	8.97e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Immune System—IL6—acquired immunodeficiency syndrome	5.72e-06	8.84e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Immune System—IL6—acquired immunodeficiency syndrome	5.72e-06	8.84e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Disease—IL6—acquired immunodeficiency syndrome	5.46e-06	8.44e-05	CbGpPWpGaD
Trifluoperazine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.33e-06	8.24e-05	CbGpPWpGaD
Trifluoperazine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.3e-06	8.2e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Disease—IL6—acquired immunodeficiency syndrome	5.28e-06	8.17e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Disease—IL6—acquired immunodeficiency syndrome	5.28e-06	8.17e-05	CbGpPWpGaD
Trifluoperazine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.68e-06	7.24e-05	CbGpPWpGaD
Trifluoperazine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.61e-06	7.12e-05	CbGpPWpGaD
Trifluoperazine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.6e-06	7.11e-05	CbGpPWpGaD
Trifluoperazine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.52e-06	6.99e-05	CbGpPWpGaD
Trifluoperazine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.51e-06	6.97e-05	CbGpPWpGaD
Trifluoperazine—CALM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.82e-06	5.91e-05	CbGpPWpGaD
Trifluoperazine—CALM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.7e-06	5.72e-05	CbGpPWpGaD
Trifluoperazine—CALM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.7e-06	5.72e-05	CbGpPWpGaD
